US · Healthcare

Interpace Biosciences Inc (IDXG)

Diagnostics & Research

Interpace Biosciences Inc (IDXG) is listed on US in the Healthcare sector. Industry: Diagnostics & Research. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for IDXG

P/E ratio

18.00

Interpace Biosciences Inc (IDXG) — FAQ

What is IDXG's P/E ratio?

The price-to-earnings (P/E) ratio for Interpace Biosciences Inc (IDXG) is 18.00 (data as of 2026-05-23).

Does Interpace Biosciences Inc pay a dividend?

Dividend yield is not available in the current snapshot for Interpace Biosciences Inc (IDXG). Check the MyAverix Finance app for the latest dividend data.

What sector is Interpace Biosciences Inc in?

Interpace Biosciences Inc (IDXG) is classified in the Healthcare sector (Diagnostics & Research industry).

What exchange is IDXG listed on?

IDXG is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)